*ST Nachuan issues third risk warning as *ST Tianlong prepares for delisting

Today’s market saw significant developments regarding delisting risks for several companies. *ST Nachuan Co., Ltd. (*ST Nachuan) and *ST Tianlong Co., Ltd. (*ST Tianlong) both issued critical announcements regarding their financial standings and potential delisting.

Earnings & Performance

• Sinofibers Technology Co., Ltd. (300777): Released its 2025 Annual Report, proposing a profit distribution plan of 2.28 yuan per 10 shares based on a total share capital of 439,146,137 shares.
• China Gold Irradiation Co., Ltd. (300962): Issued its 2025 annual audit report, receiving an unqualified opinion from auditors, confirming fair representation of its financial position.

Deals & Restructuring

• Gospell Digital Technology Co., Ltd. (*ST Gauss) (002848): Plans to issue up to 50,145,000 A-shares to raise up to 650 million RMB, resulting in a change of control.
• Ningbo Jiangfeng Electronic Materials Co., Ltd. (300666): Completed the acquisition of 15,475,627 shares of Beijing Kaide Quartz Co., Ltd., gaining control over the company.
• Zhongfu Technology Co., Ltd. (300692): Approved the acquisition of 87% of Junke Zhengyuan's equity for RMB 1 billion, aiming to enhance its biopharmaceutical capabilities.

Regulatory & Governance

• *ST Nachuan (300198): Issued its third risk warning regarding potential delisting due to negative net assets and profits, actively implementing rectification measures.
• *ST Tianlong (300029): Announced its stock is entering the delisting arrangement period, with a final delisting expected on July 9, 2026.
• *ST Sailong Co., Ltd. (002898): Issued a second risk warning about its stock entering the delisting stage, urging investor caution.
• ST Cuihua Co., Ltd. (002731): Delayed its annual and Q1 reports, facing a potential delisting risk if not filed within two months.

Other Notable Developments

• CSPC Innovation Pharmaceutical Co., Ltd. (300765): Announced the inclusion of SYS6043 in the Breakthrough Therapy list for treating specific cancers, accelerating its clinical development.
• Anker Innovations Technology Co., Ltd. (300866): Announced the listing of its H shares on the Hong Kong Stock Exchange, with net proceeds estimated at approximately HKD 4.523 billion.
• Hangxin Technology Co., Ltd. (300424): Informed investors about the upcoming suspension of trading for its convertible bonds, with the last trading day on July 2, 2026.
• Zhejiang Yonggui Electric Equipment Co., Ltd. (300351): Acquired 31.0001% of Zhejiang Yonggui Bote Transportation Equipment Co., Ltd., increasing its stake to 100%.
• Jiangsu Yawei Machine Tool Co., Ltd. (002559): Completed necessary approvals for its private placement of shares, raising RMB 657,583,954.02.